NEFL and multiple sclerosis: Recently, NfL has been identified as a sensitive and reliable biomarker of neuroaxonal damage that indicates disease severity and/or progression in various neurodegenerative diseases including, for example, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer’s, and Parkinson’s disease20–23.